GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nectar Lifesciences Ltd (BOM:532649) » Definitions » 6-1 Month Momentum %

Nectar Lifesciences (BOM:532649) 6-1 Month Momentum % : 6.27% (As of Dec. 15, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Nectar Lifesciences 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-12-15), Nectar Lifesciences's 6-1 Month Momentum % is 6.27%.

The industry rank for Nectar Lifesciences's 6-1 Month Momentum % or its related term are showing as below:

BOM:532649's 6-1 Month Momentum % is ranked better than
54.68% of 1068 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs BOM:532649: 6.27

Competitive Comparison of Nectar Lifesciences's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Nectar Lifesciences's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nectar Lifesciences's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nectar Lifesciences's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Nectar Lifesciences's 6-1 Month Momentum % falls into.



Nectar Lifesciences  (BOM:532649) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nectar Lifesciences  (BOM:532649) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Nectar Lifesciences 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Nectar Lifesciences's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nectar Lifesciences Business Description

Traded in Other Exchanges
Address
SCO 38-39, Sector 9-D, B-1011/1012, 10th Floor NAURANG HOUSE, Chandigarh, IND, 160009
Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.

Nectar Lifesciences Headlines

No Headlines